Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-18 2:42 pm Unchanged |
2020-11-17 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 7.800% |
0 (Unchanged) |
Filing History |
| 2020-11-05 08:53 am Sale |
2020-11-04 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Topspin Fund L.P. | 1,100,446 3.670% |
-2,212,178 (-66.78%) |
Filing History |
| 2020-05-11 08:45 am Purchase |
2020-05-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 3,237,333 10.820% |
3,237,333 (New Position) |
Filing History |
| 2020-05-01 5:29 pm Purchase |
2020-04-24 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
EcoR1 Capital LLC | 2,642,218 8.800% |
2,642,218 (New Position) |
Filing History |
| 2020-05-01 4:15 pm Purchase |
2020-04-28 | 13D | ORIC Pharmaceuticals, Inc. ORIC |
ORBIMED ADVISORS LLC | 2,765,717 9.200% |
2,765,717 (New Position) |
Filing History |
| 2020-04-28 7:51 pm Purchase |
2020-04-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Topspin Fund L.P. | 3,312,624 11.510% |
3,312,624 (New Position) |
Filing History |